C-XBO5Cellino
AI biomanufacturing, optical bioprocessing, regenerative medicine
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-XBO5
C-XBO5C-XBO5AI biomanufacturing, optical bioprocessing, regenerative medicine
0-100 chain-logic scale · 15 dimensions · scored on public evidence
2020 Sponsors | Wings of Freedom Fish Fry | Smyrna, TN Home Who Benefits Who We Support Grant Application Grant Recipient Report Freedom Playground Scholarship Application Sponsors Become a Sponsor 2025 Sponsors 2024 Sponsors 2023 Sponsors 2022 Sponsors 2021 Sponsors 2020 Sponsors 2019 Sponsors 2018 Sponsors Honorees Honorees Registration Classic Car Cruise-In Online Auction Photo Gallery Video Gallery Buy Tickets Here 2020 Sponsors 2020 Sponsors Thank you to all of our sponsors for supporting the 18th Annual Wings of Freedom Fish Fry. Button Button Button Button Button Button Butt … presented by the Rotary Club of Smyrna . Home Who Benefits Who We Support Grant Application Grant Recipient Report Freedom Playground Scholarship Application Sponsors Become a Sponsor 2025 Sponsors 2024 Sponsors 2023 Sponsors 2022 Sponsors 2021 Sponsors 2020 Sponsors 2019 Sponsors 2018 Sponsors Honorees Honorees Registration Classic Car Cruise-In Online Auction Photo Gallery Video Gallery © 2026 All Rights Reserved | Rotary Club of Smyrna Site Design by The I
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Hilltop’s second bike night is... - The Hilltop Inn & Grove Facebook Log In The Hilltop Inn & Grove's Post The Hilltop Inn & Grove June 26, 2023 · Shared with Public Hilltop’s second bike night is almost here!! Come see our awesome sponsors Cellino Law , 13 Monkeys Whiskey , and Security/EMT by Excelsior Management The Hilltop Inn & Grove June 25, 2023 · Shared with Public All reactions: 20 1 comment 10 shares Like Comment Most relevant 13 Monkeys Whiskey Thirteen Monkeys Whiskey Can't wait! 3y 3
Humboldt Fund Company Overview, Contact Details & Competitors | LeadIQ Learn more at LeadIQ.com Start free Insights Similar companies Tech Stack Media & News Email Format FAQ Insights Emerging Biotech Focus Humboldt Fund specializes in early-stage biotech companies, particularly in synthetic biology, providing opportunities to engage with innovative startups and explore tailored investment or partnership solutions in disruptive biotech advancements. Strategic Investment Activity Recent funding of Cellino Biotech highlights Humboldt Fund’s active role in supporting promising biotech fir … es. Limited Financial Data With low reported revenue and a small team, Humboldt Fund appears in growth or early funding stages, providing opportunities for value-added services such as fundraising platforms, financial consulting, or investment facilitation aimed at early-stage venture capital ecosystems. Similar companies to Humboldt Fund Andreessen Horowitz $1B $10B Battery Ventures $100M $250M Sequoia Capital $1B $10B Coatue $1B $10B Insight Partners $500M $1B Index Venture … RK $1M Lightspeed $250M $500M Accel $1B $10B Explore similar companies Humboldt Fund Tech Stack Humboldt Fund uses 8 technology products and services including WordPress, RSS, Font Awesome, and more. Explore Humboldt Fund 's tech stack below. WordPress Content Management System RSS Content Management System Font Awesome Font Scripts Google Cloud Infrastructure As A Service Backbone.js Javascript Frameworks JSON-LD Javascript Frameworks Google Tag Manager Tag Management Fi … nager Tag Management FitVids.js Web Tools And Plugins Media & News Humboldt Fund I, LP invested into Cellino Biotech, Inc. $80M on Jan 25th '22. Cellino Biotech announced today that they have completed Series A financing of $80 million led by the impact investment arm of Bayer AG, Leaps by Bayer, 8VC, and Humboldt Fund and includes new investor Felicis Ventures. Jan 22, 2022 | www.biospace.com Humboldt Fund 's Email Address Formats Humboldt Fund uses at least 1 fo … 's Email Address Formats Humboldt Fund uses at least 1 format(s): Humboldt Fund Email Formats Example Percentage [email protected] [email protected] 100% See more formats Frequently Asked Questions Where is Humboldt Fund 's headquarters located? Humboldt Fund 's main headquarters is located at 477 Madison Avenue 6th
Neurona Acquired by UCB for $1.15 Billion | Rebecca "Becky" Kusko, PhD posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in … s post Stem cell technology is steadily moving from research into real clinical application, with growing use in tissue repair, disease treatment and regenerative therapies. What is driving momentum is the overlap with gene editing, AI and bioengineering, which is helping researchers better understand how cells develop and respond in controlled environments. At the same time, challenges remain around regulation, scalability and manufacturing, particularly when moving from lab
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Cellino Announces Appointment of Abhijit Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Chief Business Officer - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business Cellino Announces Appointment of Abhijit Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Chief Business Officer June 27, 2022 | 3 min read Twitter LinkedIn Facebook Email Print Cellino Biotech, Inc., an autonomous cell therapy technology platform company, today announced the … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Cell therapy weekly: Cellino Biotech secures US$80 million to autonomize AI driven stem cell therapy manufacturing Skip to main content RegMedNet is part of Taylor & Francis Group. Taylor & Francis About us Our journals Our Digital Hubs Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK. Taylor & Francis Home Our journals Our journals Journal content Journal articles Follow us on social media Topics CAR-T Stem ce … illion, led by Leaps by Bayer (Leverkusen, Germany), 8VC (CA, USA) and Humboldt Fund (NY, USA). The company’s total gross proceeds reach US$96 million, with several new and existing investors including Felicis Ventures (CA, USA), The Engine (MA, USA) and Khosla Ventures (CA, USA). The manufacturing platform combines artificial intelligence and laser technology to automate cell therapy manufacturing to reduce costs and overcome scaling limitations. As part of these efforts, Ce
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Cellino Appoints Ed Tekeian as Chief Operating Officer | Cellino posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to L
Founder's Journey: Cellino CEO Nabiha Saklayen - MassVentures Programs Portfolio Resources Team Contact Us Explore funding Apply for Funding Programs Portfolio Resources Team Contact Us Programs Portfolio Resources Team Contact Us Explore funding Share Blog Founder's Journey: Cellino CEO Nabiha Saklayen Founder's Journey: Cellino CEO Nabiha Saklayen By Meg Wilcox June 2, 2021 Born in Saudi Arabia, Dr. Nabiha Sakalyen grew up in Germany and went to high school in Sri Lanka. Through her exposure to a variety of cultures, ideas and experiences, she developed a sense … the span of three months, and then met The Engine, which is a venture fund spun out of MIT, around September of that year. They wrote our first check. I'm very grateful that I was supported in that pathway, but I always made sure that I was making all the right connections, I was in the right place at the right time asking the right questions. JG: Product fit is such an important concept. There's a fine line betw … ow to resolve that. And now, that's a lot of what we do. Now, we apply AI guided laser editing to produce really high-quality stem cells for autologous cell therapies. I would never in a million years, have imagined that Cellino would be commercializing this as a platform capability today, but that's what you get from being in close contact with the right experts and listening very carefully and paying attention and not just dismissing … ng on it because it’s an ongoing process. We also, just today started rolling out our first 360 performance reviews. The management team is going first. I really believe in working on our skills to be the best versions of ourselves, for the company. I think it makes us a stronger company. JG: Can you speak a little bit about how being in Massachusetts has helped you develop this disruptive technology and build a team like yours that's … e future. Let’s build it together. Explore funding MV Capital Deep Tech Venture Fund SBIR START Grants Clean Energy Grants THRiVE Grants MV Accelerate Commercialization Accelerator Founders School SBIR Support The Fundable Founder Podcast MALSI MV Spinouts Mass Academic Spinouts Center MATTO About Us Team Mission History Resources News Releases P
%PDF-1.6 %���� 415 0 obj > endobj 421 0 obj >/Filter/FlateDecode/ID[ ]/Index[415 20]/Length 53/Prev 458915/Root 416 0 R/Size 435/Type/XRef/W[1 2 1]>>stream h�bbd``b`Z $s@�?�`���@�s(#� ����H�A�+@�)�� endstream endobj startxref 0 %%EOF 434 0 obj >stream h�b```"]ɻ�A��X��c#��a�l�� �� >/Pages 414 0 R/StructTreeRoot 66 0 R/Type/Catalog>> endobj 417 0 obj >/MediaBox[0 0 595.32 841.92]/Parent 414 0 R/Resources >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI]/XObject >>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 418 0 obj >stream h��V�k�0�W{]���l(��[ؠ�CW�A�ךԐ8%v����ɖ�4I� >�#���
Cellino Co-Founder Dr. Marinna Madrid Expands Role | Cellino | 25 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreem … ture patient-derived cells. Her leadership continues to advance the responsible application of AI across #celltherapy manufacturing and regulation. 📄 Read the full release: https://lnkd.in/gSHJGRNS #RegenMed #AIinHealthcare #PersonalizedMedicine #CellinoBio …more 137 25 Comments Like Comment Share Copy LinkedIn Facebook X Marinna Madrid, PhD 4mo Report this comment Thank you all! Like Reply 6 Reactions 7 Reactions Willie T. Reaves Jr. 4mo Report this comment Congra
Cellino Co-Founder Marinna Madrid Takes Expanded Role as ... — Cellino Biotech, Inc. | BriefGlance Skip to main content BriefGlance.com INTELLIGENCE Intelligence Market pulse Wire Media Center Contact Sign In Menu × Intelligence Market pulse Wire Media Center Contact Sign In Market Pulse Cellino Biotech, Inc. Cellino Co-Founder Marinna Madrid Takes Expanded Role as ... January 28, 2026 · 8:00 AM Cellino Co-Founder Marinna Madrid Takes Expanded Role as Chief Product and Regulatory Officer, Joins Board Event summary Dr. Marinna Madrid, co-founder of Cellino, expands role to Chief Product a
Speakers & Agenda – NYSCF Conference Skip to content Sept 23-24, 2026 The Rockefeller University About Speakers Agenda Sponsorship Submit an Abstract FAQ JAX.org About Speakers Agenda Sponsorship Submit an Abstract FAQ JAX.org register now About Speakers Agenda Sponsorship Submit an Abstract FAQ NYSCF.org About Speakers Agenda Sponsorship Submit an Abstract FAQ NYSCF.org 2025 speakers to be announced soon. 2023 Keynotes, Speakers & Chairs 2023 Keynotes Amander Clark, PhD University of California, Los Angeles Ravi Majeti, MD, PhD Stanford University view full agenda 2023 Speakers &
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Cellino Announces Chris Gibson of Recursion Joins Cellino Board | Ann DeWitt LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agre
Cellino Appoints Chris Gibson to Board of Directors | Chris Gibson LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Pr
F.elli Cellino Pasta di Sardegna — Perbacco Fine Foods Skip to Content Open Menu Close Menu Store About Us About Us Our Products Recipes Press & Events Contact us 0 0 Where to Find Us Store About Us About Us Our Products Recipes Press & Events Contact us 0 0 Where to Find Us Open Menu Close Menu Store Folder: About Us Back About Us Our Products Recipes Press & Events Contact us Where to Find Us F.elli Cellino Pasta di Sardegna F.elli Cellino pasta di sardegna. The Cellino Group was founded in the 1960’s by Ercole Cellino , who developed an ambitious entre
Press | Cellino Cellino For Patients Our Technology About Us Press Forum Join the Waitlist Press Latest News & Insights Polyphron and Cellino Show Tissue Manufacturing Works Across Any Patient Background 4.7.2026 Cellino Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 3.24.2026 The Most Innovative Biotech Companies of 2026 3.24.2026 Cellino Appoints Ed Tekeian as Chief Operating Officer 3.17.2026 Inside The Race To Reboot Human Cells - EP 60 Nabiha Saklayen 3.11.2026 Cellino Co-Founder Dr. Marinna Madrid Expands Role to Chief Product and Regulatory Officer
Cellino Appoints Chris Gibson to Board of Directors Login --> Toggle navigation --> About Mission/Vision Our Team Board of Directors Elite Members Partnerships Membership Why Join BioUtah? Membership Prospectus Member Login Apply for Membership Savings Program Non-dilutive Funding Membership Directory Advocacy Bill Tracker News/Info Life Sciences News Biosphere Magazine Podcasts Reports/Publications Events BioUtah Events Industry Events Newsletter Job Center Talent Ready Utah About Mission/Vision Our Team Board of Directors Elite Members Partnerships Membership Why Join BioUtah? Membership Pro … rs Partnerships Membership Why Join BioUtah? Membership Prospectus Member Login Apply for Membership Savings Program Non-dilutive Funding Membership Directory Advocacy Bill Tracker News/Info Life Sciences News Biosphere Magazine Podcasts Reports/Publications Events BioUtah Events Industry Events Newsletter Job Center Talent Ready Utah Join Now Join Now --> 2023 Life Sciences Day on the Hill Advisory Board Advocacy Advocacy New Annual Legislative Luncheon BIO Business Solution … O Business Solutions BIO Business Solutions 2026 Reprise BioHive BioHive Summit Award Nominations Biosphere Magazine BioUtah + Talent Ready Utah BioUtah Mission-Vision COVID-19 Resources Business Resources COVID-19 Events COVID-19 Federal News COVID-19 State News HHS/FDA News Utah’s Life Sciences Companies Workplace Safety Generic Integration Page Governance Committees GrowthZone Pages BioUtah Events BioUtah Industry Events Life Sciences Jobs Member Directory Member Log … vestment Jobs Life Sciences Reports & Publications Member Login Membership Application Membership Application Confirmation Membership Levels Member Deals Member Information Membership Directory Memberzone Networking Newsletter Non-Dilutive Government Funding Options Park City BioUtah Alliance Membership Application Confirmation Partners (New) Partnerships Privacy Policy RAPS Utah Reports Listing Sitemap social feed test Sponsors and Partners Elite Members and Partnership
Your Cells, Your Cure | Cellino Bio Cellino For Patients Our Technology About Us Press Forum Join the Waitlist Let Human Regeneration Begin Machines that reawaken your best stem cells. It starts with patients. Cell, tissue, and organ replacements are redefining treatment experiences for degenerative diseases. Our Therapies Personalized replacements address some of the most challenging diseases. Kidney Disease Spinal Cord Injury Infertility Macular Degeneration Obesity Lung Disease Urinary Incontinence Congenital Heart Disease Muscular Dystrophy Diabetes Alzheimer’s Parkinson’s Our Technology O
Cellino Biotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse Products Data Feature Plans Request Demo Sign Up for Free Last update 08 May 2025 Cellino Biotech, Inc. Startups | Holding Company | 2017 | Massachusetts, United States | 100-250 | www.cellinobio.com Startups | Holding Company | 2017 | Massachusetts, United States | 100-250 | www.cellinobio.com Last update 08 May 2025 Overview Pipeline Deal Translational Medicine Profit Grant & Funding(NIH) Investment Financing Overview Tags Nervous System Diseases Cardiovascular Diseases Other Diseases Cell therapy Induced pluripot … itions of over 360K organizations with Synapse. login or view full example data Grant & Funding(NIH) Access more than 2 million grant and funding information to elevate your research journey. login or view full example data Investment Gain insights on the latest company investments from start-ups to established corporations. login or view full example data Financing Unearth financing trends to validate and advance investment opportunities. login or view full example data
Instagram Instagram Log In Sign Up Close Never miss a post from cellinobio Sign up for Instagram to stay in the loop. Sign up Log in cellinobio Verified • Follow More options cellinobio Verified 20w Big news at Cellino! We’re excited to announce that our Co-Founder, Marinna Madrid, PhD, has expanded her role to Chief Product & Regulatory Officer and joins the Board of Directors. Marinna has been instrumental in building our #AI -integrated biomanufacturing platform, bringing together image-based machine learning, laser processing, and stem cell biology to manufacture patient-derived cells. … ture patient-derived cells. Her leadership continues to advance the responsible application of AI across #celltherapy manufacturing and regulation. 📄 Read the full release: https://lnkd.in/gSHJGRNS #RegenMed #AIinHealthcare #PersonalizedMedicine CellinoBio Load more comments ryanmariearellano 20w 🔥 Like Reply Like 12 Comment 1 Share Save January 30 Log in to like or comment. More posts from cellinobio Clip Clip Carousel Clip Clip Clip Clip Clip See more posts Meta About Blo
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Personalized Regenerative Medicines, Nabiha Saklayen, PhD, Co-Founder & CEO, Cellino Biotech — Biotech2050 Podcast Vision Episodes Newsletter Participate LP & funds Vision Episodes Newsletter Participate LP & funds Personalized Regenerative Medicines, Nabiha Saklayen, PhD, Co-Founder & CEO, Cellino Biotech Biotech2050 Podcast · Personalized regenerative medicines, Nabiha Saklayen, PhD, Co-Founder & CEO, Cellino Synopsis: Nabiha Saklayen , PhD, is the Co-Founder and CEO of Cellino Biotech , a company working to democratize access to personalized stem cell-based therapie … to our newsletter and be the first to know when new episodes air. Email Address Submit Thank you! Vision Episodes Newsletter Participate
Along the Red Line: My Scientist-Entrepreneur Journey to Reach Patients Cellino For Patients Our Technology About Us Press Forum Join the Waitlist Along the Red Line: My Scientist-Entrepreneur Journey to Reach Patients 2.25.2025 Nabiha Saklayen, PhD Co-Founder & CEO Linkedin Just yesterday, Cellino unveiled the location of our first induced Pluripotent Stem Cell (iPSC) Foundry at Mass General Hospital (MGH) in collaboration with the Mass General Brigham (MGB) Gene and Cell Therapy Institute. At Cellino, we have always made patients our North Star, making this collaboration incredibly meani
Who we are - Abc Company lingua Investment strategy Investment strategy Target companies Investment Tools Exit strategy Strategic and Financial Advisory Club Deal What Are Club Deals ABC’s Club Deals ABC Company Investors Why Choose a Club Deal with ABC Company Other Innovative Investment Solutions Investments portfolio Strategic Holdings Team Who we are Investor relations Contacts Work with us Who we are We are an independent permanent capital company listed on Euronext Growth Milan. Our Approach Mission Values Vision ABC Group Milestones Benefit Corporation ESG Our approach We invest in SMEs
Investors | The Engine Skip to content New: The Tough Tech Map. A free, open directory of infrastructure, programs, and resources for Tough Tech founders. ● Global navigation DONATE Home Explore The Engine Search Site navigation for The Engine Search The Engine Companies ↓ Open menu for Companies Resident Companies Case Studies Tough Tech Careers Board Residency ↓ Open menu for Residency Wet Labs Engineering Spaces Office Space External Facilities Resident Programs Residency Options Residency Grants Programs ↓ Open menu for Programs Blueprint by The Engine™ Whiteboard by The Engine™ Tough Tech … ls About ↓ Open menu for About Mission Team Board Host an Event Contact Support Apply for Residency Investors Invest in the future of climate tech, human health, and advanced systems. The Engine's network of investors helps our Residents access capital that understands the unique needs of Tough Tech ventures across all stages of growth. Investors gain access to companies working at the convergence of revolutionary science, engineering, and technology to solve humanity's most … engineering, and technology to solve humanity's most urgent challenges. Explore Residency options for your portfolio companies MacroCycle's pilot plant, poised to upcycle up to 200,000 plastic bottles annually. " alt="" /> Fabrication space at 750 Main Street. " alt="Engineers work with rapid prototyping tools in the fabrication space at The Engine." /> The Elastrode TM by Axoft: A soft and high-bandwidth neural interface. " alt="" /> Hyfé: Understanding impacts of feed varia … ies. Companies do not need to be funded by Engine Ventures to join The Engine’s Residency program. Learn more about Engine Ventures on their website here. Does The Engine invest in Resident companies? No. The Engine itself does not invest in companies. Instead, it connects Resident startups with a curated network of investors who understand the needs of Tough Tech founders. Engine Ventures, a separate entity partnered with The Engine, may choose to invest in some companies, b … d engineering. How can investors learn more about the companies in The Engine’s Residency program? Investors are welcome to explore The Engine’s directory of Resident companies . Investors can explore opportunities to meet companies at investor-focused events or request curated introductions from The Engine’s team. If you’re interested in meeting
This Startup Aims To Regenerate Damaged Tissues With The Help Of AI And Lasers Sign Up For Newsletters Games Share a News Tip Featured Featured Breaking News White House Watch Daily Cover Stories 2026 Forbes World's Most Influential CMOs List Making It Their Way: Six TikTok Creators On Finding A High-Quality Content Strategy That Pays Off | Paid Program The Hidden Tax On Enterprise AI: 1 In 5 Workers Lose A Full Day Every Week | Paid Program Silicon & Steel Editorial Video Series Turning Pressure Into Progress For Your Small Business | Paid Program Uniting To Advance Blood Cancer Rese … ed Research Projects Agency for Health (ARPA-H) has given Cellino a $25 million grant, adding to its $96 million in venture capital funding from firms such as Leaps by Bayer, the Engine Ventures and Khosla Ventures. Cellino plans to use the money to take what it’s doing now in automated cell growth with off-the-shelf parts and developing its own, more compact version, which could ideally be used in hospitals around the country to make treatments on demand. “We have all the fu
Leaps Portfolio Companies - YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Cellino Funding: How Much Did They Raise & Key Investors Products Product ZoomInfo Copilot AI sales agent GTM Workspace AI workspace for smarter GTM GTM Studio Build and run GTM workflows triggered by buying signals ZoomInfo MCP Connect your AI to verified B2B data Sales Company and contact database Marketing Actionable ABM platform Talent Source the best and brightest Operations Lead routing and data quality Data as a Service ZoomInfo data for your GTM systems Platform Cloud partners Ready, set, integrate Platform overview Connect industry-leading data across your entire tech stack Market … rs not publicly disclosed Series A (2022): $80M led by Bayer, 8VC, and Humboldt Fund I Key Investors in Cellino Bayer Bayer is a global life science enterprise with significant operations in healthcare and nutrition, focusing on developing solutions for major global population challenges. Their involvement suggests a strategic interest in Cellino's therapeutic applications and potential for large-scale integration. 8VC 8VC is a venture capital firm known for investing in tran … uptive potential within the biotech and regenerative medicine sectors. Humboldt Fund I Humboldt Fund I is a venture capital fund specializing in early-stage biotech companies, particularly those leveraging synthetic biology for novel production methods. Their investment aligns with Cellino's focus on innovative cell manufacturing and therapeutic development. What's next for Cellino? With its recent major strategic investment and a total funding base of $96M, Cellino is well-p
BioCentury - Cellino: Automating complex production, differentiation of iPS cells into cell therapies This Edition ARTICLE | Emerging Company Profile Cellino: Automating complex production, differentiation of iPS cells into cell therapies Via $80M A round for manufacturing play, Bayer deepens its reach into next-gen cell therapy technologies By Stephen Hansen, Associate Editor January 26, 2022 2:18 AM UTC Cellino is aiming to bring iPS cell-derived cell therapies to the masses through an automated manufacturing process that can commercially scale the reprogramming of stem cells into therapeuti … Bayer , the strategic investment arm of Bayer AG (Xetra:BAYN), 8VC and Humboldt Fund. The deal brings the Cambridge, Mass.-based biotech’s total money raised to $96 million, including a seed round from existing investors The Engine and Khosla Ventures. ... BCIQ Company Profiles Bayer AG Cellino Biotech Inc. Leaps by Bayer BCIQ Company Profiles Bayer AG Cellino Biotech Inc. Leaps by Bayer About BioCentury Privacy & Legal Contact About BioCentury Company Overview Management
Cellino Boston Jobs + Careers | Built In Boston Boston Global Tech Hub BuiltIn.com is the global destination for tech professionals. builtin.com Popular Tech Hubs United States Austin Boston Chicago Colorado Los Angeles New York City Seattle San Francisco Australia Sydney Melbourne Canada Calgary Montreal Ottawa Quebec Toronto Vancouver India Bengaluru Chennai Delhi Hyderabad Kolkata Mumbai Pune Ireland Dublin Singapore Singapore United Kingdom London Cambridge Manchester Birmingham Bristol Companies Jobs Articles Can't find your company? Create a company profile. View All Jobs Join Log I
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Cellino-Matricelf Collaboration: Leadership Discussion Verify to continue To continue, please confirm that you're a human (and not a spambot). Checking if the site connection is secure vimeo.com needs to review the security of your connection before proceeding.
Instagram Instagram Log In Sign Up Close Never miss a post from bosbizevents Sign up for Instagram to stay in the loop. Sign up Log in bosbizevents • Follow More options bosbizevents 104w Register today for our Biotech in Boston event! It will be an afternoon of informative panel discussions and a networking reception to connect with peers in the biotech industry. Don't miss this important look at how to keep biotech and related disciplines as leading growth engines of our economy for decades to come. Panels include: Where is the Exit: A look at M&A and IPO activity this year Stephani
Cell Therapy Manufacturing - August 26-27 | The Bioprocessing Summit About About the Event FAQ Social Media Wall Get Involved Attendee List Testimonials Media Gallery Agenda Conference Programs Search Agenda Training Seminars Symposia Plenary Sessions Breakout Discussions Top Pharma Presentations Speaker Biographies Networking Events Connect & Share with Your Network Track Summaries Sponsor/Exhibit Event Features & Attendee Demographics Sponsorship Opportunities Current Sponsors Exhibitor Prospectus Current Exhibitors/Floorplan Exhibit Services/Schedule Lead Generation Opportunities Ex … e Break in the Exhibit Hall with Poster Viewing (Grand Ballroom) 9:15 am Poster Award Presented in the Exhibit Hall ROOM LOCATION: Back Bay A MANUFACTURING NOVEL CELL THERAPIES 9:25 am Chairperson's Remarks Patrick J. Hanley, PhD, Assistant Research Professor, Pediatrics & Director, GMP for Immunotherapy & Cellular Lab Therapy, Children's National Health System 9:30 am The Facility Evolution of Small-Scale Cell Therapy Peter Walters, Director of Advanced Therapies, CR
Cellino | 8VC Job Board Home Resources Portfolio Fellowship About Build Our Thesis Jobs Team Contact Latest updates Posts News Feb 27, 2024 OpenGov: A Changing Guard; A Continuing Mission Today, OpenGov announced its acquisition by Cox Enterprises for $1.8 billion USD. Posts Interview Feb 7, 2024 Nik Spirin (NVIDIA) Fireside Chat For our final Chat8VC of 2023, we hosted Dr. Nik Spirin, Director of Generative AI and LLMOps at NVIDIA. He sits at a very compelling vantage point in this role. Prior to NVIDIA, he was a serial entrepreneur, classical ML PhD, and researcher by training who work … nks home portfolio Resources 8VC angel contact Company about team jobs Programs fellowship Bio-IT fellowship build Chat 8vc community privacy cookies Contact 907 South Congress Avenue, Austin, TX 78704 twitter investors ©2024 8VC. All Rights Reserved.
Cellino Closes $16M Seed Financing Led by The Engine and Khosla Ventures - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinion … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Deals Cellino Closes $16M Seed Financing Led by The Engine and Khosla Ventures February 1, 2021 | 2 min read Twitter LinkedIn Facebook Email Print The financing will be used to advance its AI-guided laser platform to automate and scale autologous cell-and tissue-based therapies. Feb. 1, 2021 13:00 UTC … cate co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC. The financing will be used to advance its AI-guided laser platform to automate and scale autologous cell-and tissue-based therapies. CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Cellino , a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the closing of a $16M Seed financing round. The round was co … was co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC. The new funding will be used to automate and scale Cellino’s transformative AI-based personalized tissue and cell platform. Cellino is developing an automated process to generate autologous induced pluripotent stem cells (iPSCs) at scale. The proprietary platform converges breakthrough technologies across optics, biology, and machine learning to engineer high functionality cells with … bsp; 2 min read · Tristan Manalac Podcast AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more June 24, 2026 · 1 min read · Jef Akst " href="https://www.biospace.com/deals/lilly-astellas-circle-sangamo-assets-as-biotech-files-for-bankruptcy" > Bankruptcy Lilly,
Polyphron and Cellino Show Tissue Manufacturing Works Across Any Patient Background - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Can … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Polyphron and Cellino Show Tissue Manufacturing Works Across Any Patient Background April 7, 2026 | 3 min read Twitter LinkedIn Facebook Email Print Polyphron and Cellino Publish Cross-Donor Tissue Engineering Results, Demonstrating Reproducible Manufacturing Across Genetically Diverse Patient Lines NEW Y … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Cellino Appoints Ed Tekeian as Chief Operating Officer - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases A … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Cellino Appoints Ed Tekeian as Chief Operating Officer March 17, 2026 | 2 min read Twitter LinkedIn Facebook Email Print CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #biotech -- Cellino , a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced the appoint … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Cellino Announces Partnership with Karis Bio to Develop First Nebula™-Powered Autologous iPSC Therapy for Cardiovascular Disease - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Cellino Announces Partnership with Karis Bio to Develop First Nebula™-Powered Autologous iPSC Therapy for Cardiovascular Disease April 15, 2025 | 2 min read Twitter LinkedIn Facebook Email Print Collaboration to Advance First-in-Human Clinical Study Using Autologous iPSC Technology CAMBRIDGE, Mass. & … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Cellino Launches U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and G … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Cellino Launches U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing February 24, 2025 | 2 min read Twitter LinkedIn Facebook Email Print Hospital-Based Foundry at Mass General Brigham Paves the Way for Decentralized, Personalized Cell and Tissue Replacements CAMBRIDGE, Mass. … and shorten the timeline from early clinical research to widespread commercial application.” The Foundry’s first clinical application focuses on a novel Parkinson’s therapy using patient-specific iPSCs. Neurosurgeon Jeffrey Schweitzer, M.D., Ph.D., the George A. Lopez, MD Endowed Chair in Neurosurgery, is leading a Phase 1 trial at Mass General Brigham. “Using a patient’s own cells as a starting point has clear advantages such as minimizing rejection risks, but making person … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Cellino and Matricelf Announce Global Collaboration to Scale Personalized Spinal Cord Injury Treatments - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Cellino and Matricelf Announce Global Collaboration to Scale Personalized Spinal Cord Injury Treatments March 11, 2025 | 3 min read Twitter LinkedIn Facebook Email Print Cellino successfully manufactures and delivers autologous iPSC lines from four donors to Matricelf for groundbreaking neural tissue engi … e iPSC production, bringing regenerative medicine closer to real-world clinical application. As a key milestone, Cellino has successfully manufactured and delivered autologous iPSC lines from four donors to Matricelf, a biotech company developing regenerative therapies for spinal cord injury. Matricelf’s approach integrates an extracellular matrix-based hydrogel derived from the patient’s own omentum, facilitating precise cell differentiation and tissue formation while elimin … r spinal cord injury, Matricelf plans to file an Investigational New Drug (IND) application next year to bring its autologous iPSC-derived therapy into clinical trials. This transformative approach addresses an urgent unmet need, potentially restoring function for millions of patients worldwide. “Collaboration on this international scale is a vital step toward our vision of a fully autologous regenerative therapy for spinal cord injury,” said Gil Hakim, CEO of Matricelf. “Mat … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Nabiha Saklayen - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Nabiha Saklayen CEO and Co-Founder Nabiha Saklayen, Ph.D., is co-founder and CEO of Cellino, a biotechnology company pioneering the world’s first fully automated, artificial intelligence (AI)–driven manufacturing technology for personalized induced pluripotent stem cell (iPSC)–derived therapies. Her vision is rooted in the belief th … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Cellino Co-Founder Dr. Marinna Madrid Expands Role to Chief Product and Regulatory Officer and Joins Board of Directors - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Cellino Co-Founder Dr. Marinna Madrid Expands Role to Chief Product and Regulatory Officer and Joins Board of Directors January 29, 2026 | 3 min read Twitter LinkedIn Facebook Email Print Expanded leadership reflects how AI is transforming both cell therapy manufacturing and the regulatory frameworks that … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Cellino Appoints Chris Gibson to Board of Directors - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business Cellino Appoints Chris Gibson to Board of Directors October 24, 2024 | 2 min read Twitter LinkedIn Facebook Email Print CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #biomanufacturing -- Cellino Biotech, Inc. , a biotechnology company advancing autonomous, closed biomanufacturing for personalized regen … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
%PDF-1.7 %���� 499 0 obj > endobj xref 499 31 0000000016 00000 n 0000002620 00000 n 0000002808 00000 n 0000002852 00000 n 0000002888 00000 n 0000004035 00000 n 0000004149 00000 n 0000004186 00000 n 0000005328 00000 n 0000006404 00000 n 0000007518 00000 n 0000008542 00000 n 0000009596 00000 n 0000010687 00000 n 0000010811 00000 n 0000011383 00000 n 0000011935 00000 n 0000012557 00000 n 0000013649 00000 n 0000014781 00000 n 0000017430 00000 n 0000022062 00000 n 0000022137 00000 n 0000022447 00000 n 0000027629 00000 n 0000029379 00000 n 0000034126 00000 n 0000037542 00000 n 0000043293 00000 n 000 … dd56a8ea628 xmp.did:c5131f8e-5586-417e-8f73-9e11cc47869c default converted from application/x-indesign to application/pdf Adobe InDesign 20.3 (Macintosh) / 2025-05-23T09:41:52+02:00 application/pdf Adobe PDF Library 17.0 False endstream endobj 498 0 obj > endobj xref 0 499 0000000000 65535 f 0000055704 00000 n 0000057355 00000 n 0000064441 00000 n 0000066194 00000 n 0000066507 00000 n 0000066643 00000 n 0000066779 00000 n 0000066915 00000 n 0000067051 00000 n 0000067187 00000 … dd56a8ea628 xmp.did:c5131f8e-5586-417e-8f73-9e11cc47869c default converted from application/x-indesign to application/pdf Adobe InDesign 20.3 (Macintosh) / 2025-05-23T09:41:52+02:00 application/pdf Adobe PDF Library 17.0 False endstream endobj 498 0 obj > endobj 500 0 obj >>> endobj 530 0 obj > endobj xref 0 1 0000000000 65535 f 497 2 0001013085 00000 n 0001017694 00000 n 500 1 0001017877 00000 n 530 1 0001018063 00000 n trailer ]/Prev 116>> startxref 1018107 %%EOF
Regenerative Medicine Collaboration and Licensing Deals 2019-2026 Your browser is not supported. To avoid security issues and to comply with web standards, please upgrade to a modern browser. ABOUT US CONTACT US FAQ  USD EUR GBP USD ▼ USD EUR GBP € EUR $ USD £ GBP +353-1-416-8900 REST OF WORLD +44-20-3973-8888 REST OF WORLD 1-917-300-0470 EAST COAST U.S 1-800-526-8630 U.S. (TOLL FREE)  Login / Register Contact Us About Us View Categories Our Services Our Services Back Market Research Custom Research Conferences & Training Subscription … rameters Clear insight into how deal terms vary by technology type, therapeutic application, and partner profile Support valuation and structuring decisions with evidence Ground internal discussions in real transaction data rather than assumptions Understand how leading companies approach dealmaking Visibility into partner behaviour and recurring deal structures across a highly innovative and cross-disciplinary therapeutic landscape Full visibility into deal structure and exe … es where disclosed Fully searchable deal directory (by company, technology, and application) Direct access to SEC-filed agreements and source documents Analysis of deal trends, key transactions, and active dealmakers A trusted, evidence-based reference for regenerative medicine dealmaking Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how regenerative medicine partnerships are structured, negotia … al Children’s Hospital Rubedo Life Sciences Rune Labs Russian Direct Investment Fund Rutgers University RxCell Rznomics S.Biomedics Sana Biotechnology SanBio Sangamo Therapeutics Sanofi Santen Pharmaceutical Santhera Pharmaceuticals Sant Joan de Déu-Barcelona Children’s Hospital Sapreme Technologies Sarah Cannon Research Institute Sarepta Therapeutics Sartorius Sartorius Stedim Biotech SATT Conectus Alsace SAVSU Technologies ScaleReady Scenic Biotech SCM Pharma Scopus BioPhar … cine Wake Forest University Walking Fish Therapeutics Walloon Region Investment Fund Walter Reed Army Institute of Research Washington University in St Louis WCTE Weizmann Institute Werum IT Solutions WhiteLab Genomics Wilson Wolf WindMIL Therapeutics Wisconsin Alumni Research Foundation Wiseman Cancer Research Foundation Wistar Institute W L Gor
Today I'm pleased to share some important progress in managing the COGS and scale issue in CGT. | Rebecca "Becky" Kusko, PhD LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking … gement of the AL Amyloidosis community as we advance toward a Biologics License Application (BLA) submission. Enrollment continues across U.S. sites, and we remain committed to advancing NXC-201 with scientific rigor and a patient-focused approach. Read the press release: https://lnkd.in/ee4PEH7P #CAR_T #Amyloidosis #CellTherapy #ClinicalTrials #Biotech #FDA #RareDiseases #IMMX 23 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Made Scientific 13 … e approaches. We removed the silos between regulatory and manufacturing, opened rolling INDs, rolling clinical trials, used Prior Knowlege approaches (ICHQ10) for QC release and stability and data supported Risk based approches (ICH Q9). And in 2022 when the EUA ended, the FDA continued the industry partnership by opening the Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP) Program What have we learned as we wrap up year 3 of the CDRP pilot?
Patrick A. Little,... - Patrick A. Little, Esq. - Cellino Law Facebook Log In Patrick A. Little, Esq. - Cellino Law's Post Patrick A. Little, Esq. - Cellino Law updated his status. January 9, 2022 · Shared with Public This content isn't available right now When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted. All reactions: 4 Like Comment
Instagram Instagram Log In Sign Up Close Never miss a post from cellinobio Sign up for Instagram to stay in the loop. Sign up Log in cellinobio and dr.nabiha_ More options cellinobio Verified 17w Why do 30,000 people descend on San Francisco for JPM every year? Because there is no substitute for the energy of being in the room. ⚡️ From running into the right people in Union Square to closing deals that only happen through serendipity, this week sets the momentum for the rest of the year. Excited to kick off 2026! #Cellino #JPM2026 #Biotech #Innovation #Healthcare Load more comments No comments
#jpmweek #jpm2025 #jpmorganhealthcare #innovation #biotech #healthcare #biomanufacturing #personalizedmedicine #regenmed #yourcellsyourcure #cellinobio | Cellino LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Joi
Dr Nabiha Saklayen on Regenerative Medicine Advancements | Cellino posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to
Cellino Careers | Levels.fyi Download App Change Login Sign Up All Data By Location By Company By Title Salary Calculator Chart Visualizations Verified Salaries Internships H-1B Salaries Negotiation Support Compare Benefits Who's Hiring 2025 Pay Report Top Paying Companies Integrate Blog Press Google Software Engineer Product Manager New York City Area Data Scientist Explore By Different Titles Levels FYI Logo Salaries 📂 All Data 🌎 By Location 🏢 By Company 🖋 By Title 🏭️ By Industry 📍 Salary Heatmap 📈 Chart Visualizations 🗺️ Atlas 🔥 Real-time Percentiles 🎓 Internships 🛂 H-1B Sal … te is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Featured Jobs No featured jobs found for Cellino Related Companies BostonGene BrainCo Cellarity BPGbio Quris AI See all companies ➜ Other Resources End of Year Pay Report Calculate Total Comp Featured Jobs No featured jobs found for Cellino Related Companies BostonGene BrainCo Cellarity BPGbio Quris AI See all companies ➜ Other Resources End of Year Pay Report Calculate Total Comp Request a
Cellino Biotech | Biotech Careers Skip to main content Biotech Careers Contact Submit an Employer Contact Add an Employer Search Open main menu Contact Submit an Employer Contact Add an Employer Search Main navigation Careers Job Areas People Articles Videos Biotech Companies Biotech Jobs Business Areas Cellino Biotech Website: Cellino Biotech Business Area(s) Stem Cells Description The company makes mixed populations of differentiated cells from stem cells for cell-based therapies. Company Location(s) 501 Mass Ave Cambridge , MA 02139 United States body Sign up for news Contact Us Add an Empl
Bioengineering Technical Leader @ Cellino | Khosla Ventures Job Board Menu Close About Portfolio Team Current Learn [email protected] [email protected] 2128 Sand Hill Road Menlo Park, CA 94025 (650) 376.8500 People Matter Join the teams that make the Impossible Happen. Search jobs Explore companies Join talent network Talent My job alerts Bioengineering Technical Leader Cellino This job is no longer accepting applications See open jobs at Cellino . See open jobs similar to " Bioengineering Technical Leader " Khosla Ventures . IT Cambridge, MA, USA Posted on Feb 3, 2026 Abo … ogy, or quantitative imaging Track record of research excellence: publications, grant applications, patents, or demonstrated technical innovation Ability to work across disciplines, communicate effectively with diverse technical and business teams, and drive initiatives from concept to delivery Nice to Have Experience with lab automation or high-throughput experimental platforms Familiarity with signaling pathway dynamics, cell fate decision-making, or embryonic development E
"Winning the Truck Wrap meant absolutely everything to us." Thanks to your votes and support, Against All Oddz Animal Alliance's mission will now be showcased throughout Western New York on a fully wrapped Cellino truck! Be on the lookout for this👀👀👀 | Cellino Plumbing, Heating, Cooling & Electric
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
JavaScript is disabled In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
The Cellino Niagara SPCA... - Cellino Law Injury Attorneys Facebook Log In Cellino Law Injury Attorneys's Post Cellino Law Injury Attorneys March 20, 2020 · Shared with Public The Cellino Niagara SPCA Cage Sponsorship Program gives businesses an opportunity to sponsor our furry friends. Join us today to help empty the cages. Head over to CellinoNiagaraSPCA.org to find out how you can help. All reactions: 13 2 comments 1 share Like Comment Most relevant Kimberly LaRussa Thank you, Ross! 6y 2 Ross Cellino replied · 1 Reply
Cellino Group | Cellino Group Home Cellino Group Divisions STAMPING LIGHT FABRICATION HEAVY FABRICATION CERTIFICATIONS CLIENTS CONTACT US it en Cellino Group specializes in steel and aluminum cold working to supply metal components for applications in industrial vehicle, earthmoving machinery, tractor, automotive engine, and energy sectors. The high level of expertise and experience in managed production processes makes Cellino Group a primary original equipment supplier for all those global customers who seek partners capable of supporting them from product development, through the subsequent … ior toward the environment and all our stakeholders Supplier Quality Excellence Award 2024 Covered area [sqm] Employees Plants in Europe HISTORY AND SUBSIDIARIES 1950 - 2000 The Cellino Group was founded in 1950 , when Ettore Cellino founded the Cellino Company, specialized in automobile bodywork. Between 1960 and 1970 the Company began its growth by moving to the Grugliasco plant; meanwhile, the core business under the leadership of Guido Cellino was focused on the
Marinna Madrid - Cellino | Biotech Showcase Speaker You need to enable JavaScript to run this app. The premier investor event January 11–13, 2027 | San Francisco, CA January 19–20, 2027 | Digital Partnering Home home About the event expand_more Biotech Showcase Get event brochure Who attends Attend expand_more Registration Options Present expand_more Company Presentation Options Presenter Resource Center Program expand_more Program Highlights 2026 Agenda 2026 Speakers partneringONE expand_more Partnering Partnering Upgrades Sponsors expand_more Sponsorship Brochure Sponsors Plan & Prepare
The Cellino family loves animals. If you do too, please join us in supporting the SPCA. Go to CellinoSPCA.org to find out how you can help for free. #spca | Cellino Law Injury Attorneys
ARPA-H announces project to scale methods for making more affordable personalized cell therapies | ARPA-H Skip to main content An official website of the United States government Here's how you know The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. About About Us Our People Partnering with ARPA-H Budget & Appr … urces and FAQs Program Portfolio Initiatives & Sprints For Small Businesses Award Directory Engage & Connect Commercialization Services ARPA-H Network International Affairs Other Transaction Community News & Events News Events Posters Careers Career Opportunities What is a Program Manager? Program Manager Application Search Breadcrumb Home / News & Events / ARPA-H announces project to scale methods for making more affordable personalize... ARPA-H announces pro … bsp; Cellino was a semi-finalist in last year’s ARPA-H Dash challenge, and this award is one of multiple projects solicited through the agency’s Open Broad Agency Announcement (Open-BAA). ARPA-H continues to seek transformative ideas for health research or technology innovation through the Mission Office Innovative Solution Openings . Continued support of each award is contingent on projects meeting aggressive milestones, typical of the ARPA-H process . To learn m … urces and FAQs Program Portfolio Initiatives & Sprints For Small Businesses Award Directory Engage & Connect Engage & Connect Commercialization Services ARPANET-H Innovation Network International Affairs Other Transaction Community News & Events News & Events News Events Posters Careers Careers Career Opportunities What is a Program Manager? Program Manager Application Policies & Information Policies & Information Accessibility Privacy Policy Freed
Scaling Manufacturing For Pers... - Business Of Biotech - Apple Podcasts Search Home New Top Charts Search 18 May 51 min Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D. Business Of Biotech Play We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Marinna Madrid, Ph.D., Cofounder, Board Member, Chief Product and Regulatory Officer at Cellino, talks about scaling up an automated manufacturing process she co-invented for personalized autologous induced pluripotent stem cell (iPSC) therapies using laser
Cellino Biotech Video Production - AVFX Skip to main content Menu Close Services Event Production Trade Show AV Design Media Production Presentation Management Event Internet Savings AVFX Denver AV Rentals AVFX Orlando AV Rentals Portfolio Event Ideas Blog Subscribe About About Us AVFX Boston AVFX Denver AVFX Orlando Careers Contact Us AVFX Boston AVFX Denver AVFX Orlando Send an RFP Menu Close Services Event Production Trade Show AV Design Media Production Presentation Management Event Internet Savings AVFX Denver AV Rentals AVFX Orlando AV Rentals Portfolio Event Ideas Blog Subscribe About A … er AVFX Orlando Careers Contact Us AVFX Boston AVFX Denver AVFX Orlando Send an RFP Cellino Biotech Video Production All Stories Event Production In the rapidly changing world of regenerative medicine, the ability to communicate groundbreaking ideas with clarity and impact is essential. That’s why Cellino Biotech partnered with AVFX and VDA, a Massachusetts-based experiential event design agency, to provide support for their international forum in Cambridge, MA. This exclusiv
Cellino - 2026 Company Profile, Team, Funding & Competitors - Tracxn JavaScript is disabled in your browser. enable it to enjoy the full features of Tracxn. Your browser was unable to load all of Tracxn resources. They may have been blocked by your firewall, proxy or browser configuration. Press Ctrl+F5 or Ctrl+Shift+R to have your browser try again and if that doesn't work, click here to retry or mail us at [email protected] Internal Server Error Toggle navigation Customers Investment Industry Venture Capital Funds Private Equity Funds Accelerators & Incubators Investment Banks Corpo … Feb 01, 2021 1456592 Seed 8885160 7983675 Khosla Ventures & 1 more Humboldt Fund & 1 more Access funding benchmarks and valuations. Sign up today! View details of Cellino 's funding rounds and investors Cellino's founders and board of directors Founder? Claim Profile The founders of Cellino are Stan Wang , Matthias Wagner , Marinna Madrid and Nabiha Saklayen . Nabiha Saklayen is the CEO of Cellino . Here are the details of Cellino's key team members: St … ss 6 funding rounds to date. The company's 1st funding round was a $ ***** Grant (prize money) round , raised on Nov 02, 2017 . Where does Cellino rank among its competitors? Cellino ranks 12th amongst 667 active competitors , of which 228 are funded. It stands 8 th in terms of total funding among its competitors. The most recent competitors to raise funding was Adocia , which secured $11.7M in Dec, 2025 . Explore our recently published companies Kandsremodelingservices
Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) | Cellino | 15 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or
Cellino, Karis Bio Partner on Autologous iPSC-Based Therapy for Cardiovascular Disease genprowebdirectory End Meta Pixel Code --> Facebook Linkedin RSS Twitter Youtube GEN Edge Featured News Multimedia Content News Insights Topics Artificial Intelligence Bioprocessing Cancer Drug Discovery Genome Editing Infectious Diseases OMICs Translational Medicine Magazine Browse Issues Subscribe Multimedia Summits Webinars GEN Live Learning Labs Podcasts Videos Resources A-Lists eBooks/Perspectives Tutorials Peer-Reviewed Journals GEN Biotechnology Re:Gen Open New Products Subscribe Get GEN Magazine Get
Regenerative Medicine Collaboration and Licensing Deals 2019-2026 Your browser is not supported. To avoid security issues and to comply with web standards, please upgrade to a modern browser. ABOUT US CONTACT US FAQ  USD EUR GBP USD ▼ USD EUR GBP € EUR $ USD £ GBP +353-1-416-8900 REST OF WORLD +44-20-3973-8888 REST OF WORLD 1-917-300-0470 EAST COAST U.S 1-800-526-8630 U.S. (TOLL FREE)  Login / Register Contact Us About Us View Categories Our Services Our Services Back Market Research Custom Research Conferences & Training Subscription … rameters Clear insight into how deal terms vary by technology type, therapeutic application, and partner profile Support valuation and structuring decisions with evidence Ground internal discussions in real transaction data rather than assumptions Understand how leading companies approach dealmaking Visibility into partner behaviour and recurring deal structures across a highly innovative and cross-disciplinary therapeutic landscape Full visibility into deal structure and exe … es where disclosed Fully searchable deal directory (by company, technology, and application) Direct access to SEC-filed agreements and source documents Analysis of deal trends, key transactions, and active dealmakers A trusted, evidence-based reference for regenerative medicine dealmaking Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how regenerative medicine partnerships are structured, negotia … al Children’s Hospital Rubedo Life Sciences Rune Labs Russian Direct Investment Fund Rutgers University RxCell Rznomics S.Biomedics Sana Biotechnology SanBio Sangamo Therapeutics Sanofi Santen Pharmaceutical Santhera Pharmaceuticals Sant Joan de Déu-Barcelona Children’s Hospital Sapreme Technologies Sarah Cannon Research Institute Sarepta Therapeutics Sartorius Sartorius Stedim Biotech SATT Conectus Alsace SAVSU Technologies ScaleReady Scenic Biotech SCM Pharma Scopus BioPhar … cine Wake Forest University Walking Fish Therapeutics Walloon Region Investment Fund Walter Reed Army Institute of Research Washington University in St Louis WCTE Weizmann Institute Werum IT Solutions WhiteLab Genomics Wilson Wolf WindMIL Therapeutics Wisconsin Alumni Research Foundation Wiseman Cancer Research Foundation Wistar Institute W L Gor
Top Personal Injury Law Firms Ranked for 2026 --> Welcome To Counsel Hound, Your Legal Journey Starts Here! Book A Free Consultation With Us Now! --> Toggle navigation Home About Us Contact Us Practice Areas Legal News & Blogs Free Consultation +1-855-804-6863 NO FEES UNTIL WE WIN TEXT US: +1-205-533-1968 Abuse Litigation Boy Scouts Abuse Clergy Abuse Lawyer Human Trafficking Elder Abuse Lyft and Uber Abuse Lawyer Nursing Home Abuse Personal Injury Lawyers Across Alabama — Free Consultation, No Fees Unless You Win Car Accident Lawyer Motorcycle Accidents Drunk Driver Liability and Dram Sh … ion success: a $40 million talc trial verdict in December 2025, a $25.8 million award against Terminix for fumigation injuries in March 2026, a $13.8 million medical malpractice verdict in March 2026, and a $10 million on-the-job injury settlement in February 2026. Beasley Allen has been ranked in the National Law Journal’s list of top plaintiff firms for over 20 consecutive years. The firm’s depth in product liability and mass torts makes it uniquely relevant for readers com
rxrx-20260430 0001601830 DEF 14A FALSE iso4217:USD 0001601830 2025-01-01 2025-12-31 0001601830 2024-01-01 2024-12-31 0001601830 2023-01-01 2023-12-31 0001601830 2022-01-01 2022-12-31 0001601830 2021-01-01 2021-12-31 0001601830 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2025-01-01 2025-12-31 0001601830 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2025-01-01 2025-12-31 0001601830 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2025-01-01 2025-12-31 0001601830 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonP … RX2026 . You will be able to attend the meeting online, vote electronically and submit questions by registering at www.virtualshareholdermeeting.com/RXRX2026 15 minutes prior to the meeting start time of 12:00 P.M. Mountain Time. Our Board of Directors (the “Board of Directors,” “Board,” or “our Board”) has fixed the Stockholders of record date at the close of business on April 21, 2026 (the “record date”). Stockholders as of th … cted and qualified, or until his or her earliest death, resignation or removal (Proposal 1); TO HOLD AN ADVISORY VOTE to approve the compensation of our Named Executive Officers, as disclosed in the proxy statement accompanying this notice (Proposal 2); TO RATIFY the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 (Proposal 3); and TO TRANSACT any other business properly brou … THE ANNUAL MEETING AND VOTING 7 BOARD OF DIRECTORS AND CORPORATE GOVERNANCE 11 PROPOSAL 1 : ELECTION OF DIRECTORS 23 PROPOSAL 2: ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION 31 EXECUTIVE COMPENSATION 33 EXECUTIVE COMPENSATION TABLES 45 PROPOSAL 3: RATIFICATION OF APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP 55 REPORT OF THE AUDIT COMMITTEE 58 EXECUTIVE OFFICERS 59 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 60 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND  … NG STATEMENTS 66 Proxy Summary PROPOSALS TO BE VOTED UPON AT THE ANNUAL MEETING Proposal Description Board Recommendation Page Reference 1 To elect t wo Class I I D irectors to our B oard of D irectors, to serve until the 202 9 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her e
Instagram Instagram Log In Sign Up Close Never miss a post from cellinolaw Sign up for Instagram to stay in the loop. Sign up Log in cellinolaw • Follow More options cellinolaw 1w In a ride-share accident? 🚗 Even as a passenger, take photos and document the scene. Who’s at fault matters. Let Cellino Law help protect your rights. 📞 Call the 8s. #CellinoLaw #UberAccident #LyftAccident #PersonalInjuryAttorney #InjuryClaims Load more comments No comments yet. Start the conversation. Like 3 Comment Share Save June 12 Log in to like or comment. More posts from cellinolaw Clip Clip Clip Clip Clip C
How Cellino Bio Streamlined Hardware Collaboration with Bild Product Solutions Version Control Change Management Supplier Collaboration BOM Management Industries Aerospace and Defense Automotive Robotics and Industry 4.0 Medical Devices Product Design Meru AI Solutions Meru Overview Delta: CAD Difference Analyzer Echo: Semantic Search Sigma: Automated Reporting (Coming Soon) Partner Program Integrations Pricing Blog See the Demo Sign Up Sign In See the Demo Sign Up Blog Case Study How Cellino Bio Streamlined Hardware Collaboration with Bild Cellino is a biotechnology company developing advance
Cellino | The Engine Skip to content New: The Tough Tech Map. A free, open directory of infrastructure, programs, and resources for Tough Tech founders. ● Global navigation DONATE Home Explore The Engine Search Site navigation for The Engine Search The Engine Companies ↓ Open menu for Companies Resident Companies Case Studies Tough Tech Careers Board Residency ↓ Open menu for Residency Wet Labs Engineering Spaces Office Space External Facilities Resident Programs Residency Options Residency Grants Programs ↓ Open menu for Programs Blueprint by The Engine™ Whiteboard by The Engine™ Tough Tech W … ls About ↓ Open menu for About Mission Team Board Host an Event Contact Support Apply for Residency < Back to resident companies Cellino Investment areas Applied AI & ML Biotech / Life Sciences Manufacturing Founders & Leadership Nabiha Saklayen Marinna Madrid Matthias Wagner Abhijit Kulkarni Headquarters Cambridge, MA Cellino on twitter Cellino on linkedin Visit cellinobio.com Automating personalized medicine to cure the world's toughest diseases. The Tough T … on linkedin Sign up for The Engine newsletter Add your email address Companies Residency Programs Resources Ecosystem Support About Team Careers with The Engine Host an Event at The Engine Contact Privacy Policy Engine Ventures Close The Engine We support Tough Tech teams The Engine is a non-profit incubator and accelerator that supports Tough Tech teams working to solve the world’s toughest challenges through the convergence of science, engineering and entrepreneurship. We … hnologies on their journey from idea to impact. Follow us on linkedin Companies Residency Programs Resources Ecosystem Support About Team Careers with The Engine Host an Event at The Engine Contact Privacy Policy Interested in joining our ecosystem? Get in touch. Contact Us Engine Ventures
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
Cellino | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Life Sciences / Companies Cellino Cellino Bio is dedicated to transforming treatment experiences for degenerative diseases through personalized regenerative medicine. Utilizing proprietary AI-driven optical bioprocesses and advanced biomanufacturing technologies, the company aims to make patient-specific cell, tissue, and organ replacements widely accessible. Their mission is to unlock the power of personalized regenerative medicine to address challenging diseases and improve patient outcomes. … ces Nabiha Saklayen of Cellino as an Entrepreneur Of The Year® 2025 New England Award Winner Cellino Secures FDA AMT Designation for Automated iPSC Manufacturing Platform Cellino’s iPSC Manufacturing Technology Receives FDA AMT Designation Cellino’s iPSC Manufacturing Technology Receives FDA Advanced Manufacturing Technology (AMT) Designation Scalable Manufacturing: The Make-or-Break Factor for Cell, Gene, and Tissue Therapies Engineering New Blood Vessels: The Future of iPSC … ces Nabiha Saklayen of Cellino as an Entrepreneur Of The Year® 2025 New England Award Winner Cellino Secures FDA AMT Designation for Automated iPSC Manufacturing Platform Cellino’s iPSC Manufacturing Technology Receives FDA AMT Designation Cellino’s iPSC Manufacturing Technology Receives FDA Advanced Manufacturing Technology (AMT) Designation Scalable Manufacturing: The Make-or-Break Factor for Cell, Gene, and Tissue Therapies Engineering New Blood Vessels: The Future of iPSC
Cellino Builds the Future of Regenerative Medicine at The Engine |… Skip to content New: The Tough Tech Map. A free, open directory of infrastructure, programs, and resources for Tough Tech founders. ● Global navigation DONATE Home Explore The Engine Search Site navigation for The Engine Search The Engine Companies ↓ Open menu for Companies Resident Companies Case Studies Tough Tech Careers Board Residency ↓ Open menu for Residency Wet Labs Engineering Spaces Office Space External Facilities Resident Programs Residency Options Residency Grants Programs ↓ Open menu for Programs Blueprint by The … ls About ↓ Open menu for About Mission Team Board Host an Event Contact Support Apply for Residency Cellino Builds the Future of Regenerative Medicine at The Engine Industries Applied AI/ML Biotech / Life Sciences Manufacturing Founders & Leadership Nabiha Saklayen, Marinna Madrid, Matthias Wagner, Abhijit Kulkarni Founded 2017 Joined The Engine 2018 Spaces and Equipment Used Dedicated Wet Labs Dedicated Engineering Space Dedicated Office Space General Amenities Website c … g former First Lady Jill Biden — efforts that ultimately led to the $25 million award for Cellino. Cellino is paving the way for a future of truly personalized treatments: not just managing disease, but curing it, with safer and more accessible treatments for cell, tissue, and organ replacements and longer, healthier lives for millions of people. They represent the best of what’s possible at The Engine — a place where companies come to find the resources and support they need … and support they need to tackle the biggest challenges facing society. Explore Residency Options The Engine We support Tough Tech teams The Engine is a non-profit incubator and accelerator that supports Tough Tech teams working to solve the world’s toughest challenges through the convergence of science, engineering and entrepreneurship. We provide access to comprehensive programming, specialized spaces and equipment, and the ecosystem to support transformative technologies o … on linkedin Sign up for The Engine newsletter Add your email address Companies Residency Programs Resources Ecosystem Support About Team Careers with The Engine Host an Event at The Engine Contact Privacy Policy Engine Ventures Close The Engine We support Tough Tech teams The Engine is a non-profit incubator and accelerator that supports Tough T
Cellino | Engine Ventures Skip to content We are seeking an Associate to join our investment team | Apply now! Engine Ventures Site navigation for Engine Ventures About , Portfolio , Connect , News Global navigation Explore Cellino Curing the world’s toughest diseases by automating personalized medicine. Founders & Leadership Nabiha Saklayen, Matthias Wagner, Marinna Madrid Background Harvard Physics Department, Harvard School of Engineering and Applied Sciences (SEAS), Harvard Medical School Industries Advanced Engineering and Manufacturing , AI‑Enabled Physical Systems … ost every single one can be programmed from one of these special cells. A Nobel prize-winning discovery, iPS cells have helped transform the possibilities of tissue engineering. Yet, even with their potential, persuading iPS cells to produce functionally mature tissues has been challenging for therapeutic use. Until now. Cellino has built the first platform that enables precise control over iPS cell fate in their natural environment. The Cellino Tissue Engineering Platform ma … and HIV. Her pitch bested those of 130 other companies to win the $15,000 grand prize, beating established corporate players and academic teams. The Startup Challenge victory made something clear to Saklayen: she and Madrid needed to get smart about engineering and biology. Quickly. Enter Matthias Wagner, who joined the team shortly after the competition. Wagner, a successful entrepreneur and founder in his own right, is an expert in photonics, machine learning, and bringing … Close Engine Ventures About The Firm The Team Portfolio Connect Engine Ventures Fellowship Entrepreneurial Fellowship Pathways Frontier Forum Tough Tech Job Board News Contact Careers Search Search The Engine Login: navigation for Engine Ventures LP Login Linkedin
Who Owns Cellino Company? – businessmodelcanvastemplate.com Skip to content Framework Templates Blogs Search Cart 0 / $0.00 Who Owns Cellino Company? July 11, 2025 CELLINO BUNDLE Get the Full Package: 5 Forces $15 $10 BCG Matrix $15 $10 Canvas $15 $10 Marketing Mix $15 $10 PESTLE $15 $10 SWOT Analysis $15 $10 TOTAL: ADD TO CART Who Really Owns Cellino Company? Unraveling the ownership structure of Cellino Canvas Business Model is key to understanding its future. Cellino, a pioneer in automated cell manufacturing, is reshaping personalized cell therapies, but who's steering the ship? This … Society for Optics and Photonics conference in 2017, which won a $15,000 grand prize, validated the commercial potential of their technology. Early Funding Early funding rounds, including seed rounds, indicated initial backing from angel investors and venture capital firms. The initial success of Cellino Company was built on the founders' research, with early validation coming from winning the Startup Challenge at the Society for Optics and Photonics conference in 2017. This … 2022. This round was spearheaded by Leaps by Bayer, alongside 8VC and Humboldt Fund. New investors such as Felicis Ventures joined existing ones, including The Engine and Khosla Ventures. This Series A round boosted Cellino's total gross proceeds from private financings to $96 million at that time. More recently, on September 18, 2024, the company received a $25 million grant from the Advanced Research Projects Agency for Health (ARPA-H) to advance its biomanufacturing techn … ing technology. Funding Round Date Amount Series A January 25, 2022 $80 million Grant September 18, 2024 $25 million Total Funding Across six rounds $125 million The major stakeholders in the Cellino Company include its founders: Nabiha Saklayen, Matthias Wagner, Marinna Madrid, and Stan Wang. Institutional investors and venture capital firms also hold significant ownership stakes. Key investors include Leaps by Bayer, 8VC, Khosla Ventures, Engine Ventures, Felicis Ventures, … by Bayer, 8VC, Khosla Ventures, Engine Ventures, Felicis Ventures, and Humboldt Fund. These investments have been instrumental in driving the company's strategy, supporting the expansion of its machine learning, software, and hardware capabilities for cell therapy manufacturing. For more details on the Cellino business, you can read this article
We Are Cellino | Cellino Cellino For Patients Our Technology About Us Press Forum Join the Waitlist We Are Cellino. Committed to driving a healthspan renaissance. Our Values Seek Unity One team, one mission Be Brave Face challenges head-on Show Kindness Be the reason someone smiles Our Cellineers Alexander Stange, PhD Principal R&D Engineer, FMS Tech Lead August Lin Bioengineer I Blair Morad Senior Director of Systems Engineering Brian Smith Senior Mechanical Engineer Catherine Pilsmaker, MS Manager and Lead Bioengineer Chi-Wen Lo, PhD Senior Scientist, Analytical Development Daeyoung Kim
%PDF-1.7 %���� 482 0 obj > endobj 510 0 obj >/Filter/FlateDecode/ID[ ]/Index[482 41]/Info 481 0 R/Length 126/Prev 1972769/Root 483 0 R/Size 523/Type/XRef/W[1 3 1]>>stream h�bbd```b``���-`r%�d� "�L@$�X\DrG��>C�;�� &���W�Iw���Լ f�����V�f{IF�f0�D��e@��4X� H��j�����X��E�g`4�`g�q endstream endobj startxref 0 %%EOF 522 0 obj >stream h�b```�� �@r��0�0�1�!gF'�E'�����0rX�c����T�u��Z�-�R֪-� D�6��3� Ma� ��0}BX����2s{V%��v��1pdj�Y�r��B���G^LQ��U�d�Ϊ��b+ �Y��46� =-�)��� >/Metadata 184 0 R/Outlines 389 0 R/Pages 476 0 R/StructTreeRoot 412 0 R/Type/Catalog>> en … 0496d35-5957-4484-9151-2a50f4d96507 uuid:7d9401a5-94da-4fc3-bda7-52c723248c49 2 application/pdf Ken Martin Adobe PDF Library 15.0 D:20200819125523 National Fuel Gas endstream endobj 182 0 obj >stream PDFCreator 3.3.0.2468 2019-11-02T18:25:18-04:00 2019-11-02T18:25:18-04:00 PDFCreator 3.3.0.2468 uuid:26293067-001b-11ea-0000-0eecdc6e1231 uuid:26293067-001b-11ea-0000-0eecdc6e1231 application/pdf bakerk endstream endobj 183 0 obj >stream hޔW]S�8�O�[�am���k��>�N�B���>0 X����>�` … -20T17:41:11-04:00 2020-08-20T17:41:11-04:00 Adobe Acrobat Pro 2017 17.11.30175 application/pdf Ken Martin uuid:6dd2819a-d6c6-4eac-985c-c0522f545b61 uuid:f7363cf7-f844-4c2e-8955-5878c231035c Adobe Acrobat Pro 2017 17.11.30175 endstream endobj 185 0 obj >stream hޔ�� 1Ee� �$������Ͳ؉łAlT\-�{cn����@�{�N�"Y ]G�$���JΕ�dɩRߛ��~��c�>��k��T��%P�3��%�q>�e�ii��0�u�T���8_sI��n���� �����tܙ�C�w]�N�Qx��F����)��j' endstream endobj 186 0 obj >stream hތ�A �0���6��i�R�&~ mJ
Lonza Group - We have just launched an enhanced integrated... Facebook Log In Lonza Group's Post Lonza Group Verified account June 3 at 5:04 AM · Shared with Public We have just launched an enhanced integrated DNA-to-IND offering, designed to help customers accelerate timelines while minimizing development risk. The offering builds upon our industry-leading and decision-enabling early de-risking capabilities, as well as preclinical development track record, and enables faster progression to the clinic, with toxicology material available in approximately two months and IND filing readiness
Instagram Instagram Log In Sign Up Close Never miss a post from dr.nabiha_ Sign up for Instagram to stay in the loop. Sign up Log in dr.nabiha_ Verified • Follow More options dr.nabiha_ Verified 4w How did Cellino get its name? Inspired by a star in the Pleiades cluster, Celaeno. Changed the spelling to Cellino, blending 'cell' and 'innovation'. It stuck, and even helped win a startup competition! #StartupStory #CompanyNaming #Entrepreneurship #Innovation #Pleiades #Celaeno #Cellino #FounderJourney #TechStartup Load more comments No comments yet. Start the conversation. Lik
Instagram Instagram Log In Sign Up Close Never miss a post from trainwrecksports Sign up for Instagram to stay in the loop. Sign up Log in trainwrecksports and cellinoplumbing_hvac More options trainwrecksports 14w There are only a few more hours left to vote for your favorite nonprofit into the Top 8 of this year's Cellino Truck Wrap Contest! Here are the remaining 16: Sophia the Fierce Inc. Diamonds in the Ruff Against All Oddz Animal Alliance Inc. Queen City Pitties Animal Rescue Cherry Hill Farm Sanctuary Nickel City Canine Rescue Kaely's Kindness Foundation Second Chance Shelter
Cellino launches first iPSC Foundry at Mass General | Cellino posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Link
Marinna Madrid - BIO International Convention 2026 Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! Save the date: June 7-10, 2027 BIO is back in Philadelphia in 2027! June 7-10 | Philadelphia Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule at a Glance FAQs International Visitors Why Attend Visa Invitation Letter Request Tips for International Visitors Share On Social Media For Press Media Resource Center Media Registration Engaging with the Media Request Media List Press Releases Stay in Touch Contact Us Join our mailing … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Partnering Companies … Amgen Genentech Boehringer Ingelheim Lilly Novo Nordisk Sanofi Academic Campus Apply for Academic Campus Exhibition Directory and Map Event Directory Exhibitor List Exhibitor In-Booth Events Event Map Exhibition Hours Exhibition Reception BIO Booths BIO Business Solutions® Pavilion BIO Member Lounge Networking BIO Receptions Other Events Social Spotlight Events Affiliate Events Application Special Experiences 5K and 1 Mile Course BIO Gives Back Headshot Lounge Matchday Loung … tion of physics and biotechnology, Dr. Madrid has received the Harvard Graduate Prize Fellowship, the Catalyst Accelerator Grant from Harvard Medical School, and was named to the Forbes 30 Under 30 list in Healthcare. She continues to champion the convergence of deep tech and biology to make precision medicine accessible to every patient. BIO DOUBLE HELIX SPONSORS Our sponsors help support BIO's mission to support and advocate for the biotechnology industry. Loading BIO HELIX
%PDF-1.5 %���� 317 0 obj > endobj xref 317 58 0000000016 00000 n 0000002844 00000 n 0000002958 00000 n 0000004154 00000 n 0000004422 00000 n 0000004975 00000 n 0000005519 00000 n 0000005925 00000 n 0000006346 00000 n 0000006383 00000 n 0000006645 00000 n 0000006757 00000 n 0000006871 00000 n 0000007455 00000 n 0000007716 00000 n 0000008321 00000 n 0000010333 00000 n 0000011935 00000 n 0000013852 00000 n 0000015690 00000 n 0000017452 00000 n 0000019593 00000 n 0000019956 00000 n 0000020226 00000 n 0000020310 00000 n 0000020894 00000 n 0000021188 00000 n 0000021737 00000 n 0000023501 00000 n 000 … ��]�oiPi� ��껫K������{���.���D�[ > endobj 355 0 obj > endobj 356 0 obj >stream application/postscript MLSC_Logomark_RGB Martha Abdella 2019-12-02T09:48:30-05:00 2019-12-02T09:48:30-05:00 2019-12-02T09:48:30-05:00 Adobe Illustrator CC 23.1 (Macintosh) xmp.iid:5b3da7b0-e8e2-422b-bd23-6c0a3ddea8eb xmp.did:5b3da7b0-e8e2-422b-bd23-6c0a3ddea8eb uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:07fee8a5-8c6d-43dd-b976-9d33b092a2c0 xmp.did:07fee8a5-8c6d-43dd-b976-9d33b092a2c0 … 019-08-30T09:20:08-04:00 Adobe Illustrator CC 23.0 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:07fee8a5-8c6d-43dd-b976-9d33b092a2c0 2019-12-02T09:48:07-05:00 Adobe Illustrator CC 23.1 (Macintosh) / saved xmp.iid:5b3da7b0-e8e2-422b-bd23-6c0a3ddea8eb 2019-12-02T09:48:30-05:00 Adobe Illustrator CC 23.1 (Macintosh) / Print False False 1 1198.530912 362.801614 Pixels Nunito-Light Nunito Light Regular TrueType Version 3.000 … D��v�̜%�{���w6�2� 0 :R endstream endobj 192 0 obj > endobj 193 0 obj >stream application/postscript Twitter_Social-Icon_Circle_White-on-Color Kelsey Jones 2017-07-21T15:49:03-07:00 2017-07-21T15:49:03-07:00 2017-07-21T15:49:02-07:00 Adobe Illustrator CC 2015 (Macintosh) xmp.iid:71f3f385-e1da-45e9-b657-1843ea40ad94 xmp.did:71f3f385-e1da-45e9-b657-1843ea40ad94 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:d23eb5e2-62c1-451c-8413-ed0ebcc43b3a xmp.did:d23eb5e2-62c1-4 … 6-06-29T14:59:31-07:00 Adobe Illustrator CC 2015.3 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:d2983d08-f7a5-471f-8f3c-2c5ebf4995a9 2016-06
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
Cellino Bio Future Human Login Subscribe Future Human Home Posts Cellino Bio Cellino Bio Personalized Biological Repair Andrew Kuzemczak Aug 7, 2025 In partnership with Training cutting edge AI? Unlock the data advantage today. If you’re building or fine-tuning generative AI models, this guide is your shortcut to smarter AI model training . Learn how Shutterstock’s multimodal datasets—grounded in measurable user behavior—can help you reduce legal risk, boost creative diversity, and improve model reliability. Inside, you’ll uncover why scraped data and aesthetic proxies often fall short—and how … ise has attracted over $120 million in funding to date, including a $25 million grant from the federal government’s ARPA-H program. 4 , 5 Backed by FDA’s Advanced Manufacturing Technology designation and now building its first foundry at Mass General Brigham’s Gene and Cell Therapy Institute, Cellino is pushing hard to industrialize the production of regenerative cell therapies. It’s also begun forging strategic alliances, including a partnership with Matricelf to develop spi
Cellino Collaboration Advances Tissue Mapping and Genotype-Matched Manufacturing | Fabio Boniolo posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to … technologies are rapidly closing the gap between laboratory models and clinical application. As these systems move toward therapeutic use, urgent challenges remain around scalability, standardisation, and automated workflows. This Special Issue invites original research, reviews, and methods contributions on spheroids, organoids, tumoroids, scaffold-based and scaffold-free platforms, extracellular vesicle manufacturing, cryopreservation strategies, and regulatory science fram … re about the Special Issue using the link below: https://brnw.ch/21x1FHL 🕑 The deadline for manuscript submissions is 25 November 2026. 🎉 We warmly invite you to contribute as authors and reviewers! Please feel free to follow our LinkedIn account Bioengineering MDPI ! #MDPI #OpenAccess #Bioengineering #3DCellCulture #Bioreactors #TissueEngineering #Organoids #OrganOnChip Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Maryam Mirlohi 2mo Report
Leaps by Bayer - Annual Review 2025 | Cellino LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Co … Dr. Dr. Nabiha Saklayen with the EY Entrepreneur Of The Year® 2025 New England Award for leadership in transforming cell therapy manufacturing We’re thankful to the Leaps team for being thoughtful, long-term partners, and supporting us to build the infrastructure needed to make regenerative medicine a reality for patients. Congratulations to the entire Leaps team on an incredible 10 years of impact, and for believing in what we’re building. #LeapsByBayer #RegenerativeMedicin
LE VIGNE DI SAMMARCO SRL of Cellino San Marco (BR) at ProWein 2026 in Düsseldorf -- ProWein Trade Fair Skip to main content Main navigation Close Back --> --> --> Home Exhibit Trade Fair Participation Online Registration Become an exhibitor Stand Cost Calculator ProSpirits Organic World ProWein Zero Information Contact persons Download-Center At a glance Service-ABC Hotel & CityInfos Stand Builder Portal WEINIMPORT Aktuell Services for exhibitors Fair Match Online-Order-System (OOS) Exhibitor Profile Exhibitor Dashboard Exhibitor passes Vouchers Scan2Lead Logos & Banner Trade Fair Presence Sta … Press Accreditation Press contact Press release Exhibit Exhibit Exhibit Online application Online Order System Marketing Services Exhibitor contact Dashboard International trade fairs International trade fairs International trade fairs ProWein Hong Kong ProWine São Paulo ProWine Shanghai ProWine Mumbai ProWine Singapore ProWine Tokyo About ProWein About ProWein About ProWein Product categories Facts & figures Newsletter Blog / Magazin Contact & Support Write to us Hotline +4
PASTIFICIO CELLINO - Online Guidebook | FOODEX JAPAN 2026 / 2026 Japan Meat Industry Fair 50th Online Guidebook DATE March 10 (Tue) - 13 (Fri), 2026 VENUE Tokyo Big Sight LOGIN JP Exhibitor's List Search Exhibitors Search Exhibit Products Invitation application form Visitor Pre-registration PASTIFICIO CELLINO https://www.pastacellino.it National Pavilion Booth number W2-K29-061 Overseas exhibitors Exportable Co-exhibitor Organizer : Italian Pavilion Inquiry to exhibitor PASTIFICIO CELLINO BOOTH N.61 WEST HALL 2 - ITALIAN PAVILION Country / Region ITALY Exhibited products DURUM WHEAT PASTA, ITA